Wu, Di http://orcid.org/0000-0001-9748-4408
Tang, Haiping http://orcid.org/0000-0003-4526-5099
Qiu, Xingyu
Song, Siyuan http://orcid.org/0009-0005-8278-3954
Chen, Siyun
Robinson, Carol V. http://orcid.org/0000-0001-7829-5505
Funding for this research was provided by:
Wellcome Trust (221795/Z/20/Z)
Wellcome Trust (221795/Z/20/Z.)
Wellcome Trust (221795/Z/20/Z.)
Wellcome Trust (221795/Z/20/Z.)
Wellcome Trust (221795/Z/20/Z.)
Wellcome Trust (221795/Z/20/Z.)
Article History
Received: 13 March 2024
Accepted: 6 June 2024
First Online: 22 August 2024
Competing interests
: C.V.R. is a cofounder and consultant of OMass Therapeutics. The other authors declare no competing interests.